--Cognizant announced a five-year extension of its work with Gilead Sciences, a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades. "Our focus is on giving our teams reliable, efficient technology that helps them move important work forward," said Anna Berg Asberg, Global CIO, Gilead.

Cognizant announced a five-year extension of its work with Gilead Sciences, a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades. Under...

/PRNewswire/ -- Cognizant anunció una extensión de cinco años de su trabajo con Gilead Sciences, una compañía biofarmacéutica que ha perseguido y logrado...

Cognizant Technology Solutions (CTSH) ha lanzado una nueva unidad de negocio diseñada para proporcionar artificia

/PRNewswire/ -- Cognizant (Nasdaq: CTSH), a leading AI builder and technology services provider, today announced the launch of Cognizant Activate, a new...

New business unit designed to deliver enterprise-grade AI transformation to emerging enterprises that generate $1 billion to $5 billion in annual revenue, building toward Global 2000 scale,...

Cognizant Technology Solutions Corporation (NASDAQ:CTSH - Get Free Report) has earned a consensus rating of "Hold" from the twenty-four ratings firms that are presently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating, thirteen have issued a hold rating and t

Cognizant stock was at EUR 51.93 after-hours at 9:36 p.m. CEST on October 2, 2026, down 4.05 percent

Q2 revenue hit USD 5.48 billion, up 4.50 percent year over year. Cognizant stock costs EUR 54.70 on

Cognizant (Nasdaq: CTSH), a leading AI builder and technology services provider, will announce results for the third quarter of 2026 on Thursday, October 29, 2026 before market open. Following the...

CX Institutional boosted its stake in shares of Cognizant Technology Solutions Corporation (NASDAQ:CTSH - Free Report) by 19.0% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 161,341 shares of the informa